SageView Advisory Group’s Sanofi SNY Stock Holding History

SageView Advisory Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,022	Closed	-$1.41M	–	2152
2025 Q4	$1.41M	Sell	29,022 -1,528	-5%	-$75.7K	0.05%	209
2025 Q3	$1.44M	Buy	+30,550	New	+$1.47M	0.05%	216
2025 Q2	–	Sell	-5,364	Closed	-$297K	–	637
2025 Q1	$297K	Sell	5,364 -863	-14%	-$46.7K	0.01%	472
2024 Q4	$300K	Buy	+6,227	New	+$317K	0.01%	465

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SageView Advisory Group's SNY Position: Q1 2026 in Review

SageView Advisory Group sold out of Sanofi (SNY) in Q1 2026, closing a stake of 29,022 shares — an estimated $1.41M sold.

SageView Advisory Group first reported a position in SNY in Q4 2024 and held it in 4 quarters. The position peaked at $1.44M in Q3 2025. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

SageView Advisory Group reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 29,022 Sanofi shares in Q1 2026, an estimated $1.41M.
SageView Advisory Group first reported a position in Sanofi in Q4 2024 and held it in 4 quarters.
SageView Advisory Group's Sanofi position peaked at $1.44M in Q3 2025.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.